MorphoSys initiates phase 1b clinical trial with MOR103

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

MorphoSys initiates phase 1b clinical trial with MOR103

Postby MSUK » Wed Dec 21, 2011 1:22 am


MorphoSys AG announced today that a phase 1b clinical trial evaluating MOR103, a human monoclonal antibody to GM-CSF (granulocyte macrophage-colony stimulating factor), in patients with multiple sclerosis (MS) is now open for enrollment, thereby adding a second indication to the development program.

A phase 1b/2a trial in patients with active rheumatoid arthritis is ongoing and is on track to report data by mid of 2012. Additionally, a phase 1 pharmacokinetic (PK) study in healthy volunteers to evaluate a subcutaneous formulation of MOR103 will commence shortly....Read More - ... ageid/1397
User avatar
Family Elder
Posts: 2469
Joined: Wed Oct 14, 2009 3:00 pm


Return to General Discussion


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service